Oblenio Bio
Series BOblenio Bio is a privately held company based in United States. The latest disclosed round is Series B ($62m), dated Jun 25, 2026. Institutional investors on record include Google Ventures.
United States
What is Oblenio Bio?
Oblenio Bio is a privately held company based in United States. The latest disclosed round is Series B ($62m), dated Jun 25, 2026. Institutional investors on record include Google Ventures. Developer of tri-specific T-cell engager therapies for autoimmune disease treatment. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Oblenio Bio?
Who invested in Oblenio Bio?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Google Ventures | Series B | $62m | Jun 25, 2026 |
What do founders ask about Oblenio Bio?
What is Oblenio Bio?
Oblenio Bio is a privately held company based in United States. The latest disclosed round is Series B ($62m), dated Jun 25, 2026. Institutional investors on record include Google Ventures. Developer of tri-specific T-cell engager therapies for autoimmune disease treatment. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Oblenio Bio's last funding round?
Oblenio Bio's latest disclosed round is Series B at $62m (Jun 25, 2026).
Who invested in Oblenio Bio?
Oblenio Bio has 1 institutional investors on this page, including Google Ventures.
How does CrackTheDeck cover Oblenio Bio?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Oblenio Bio card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.